HADV — Health Advance Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.38m
- $0.42m
- $0.02m
Annual income statement for Health Advance, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2014 July 31st | 2015 July 31st | 2016 July 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.01 | 0.02 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | — | — |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 0.072 | 0.067 | 0.029 | 0.008 | 0.042 |
| Operating Profit | -0.072 | -0.067 | -0.029 | 0.002 | -0.022 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.003 | -0.003 | -0.001 | 0 | 0 |
| Dividends per Share |